Endocrine Myopathies: Clinical Review

  • Yeter H
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Endocrinopathy is generally associated with hormonally-mediated systemic disorders. Myopathy is a result of this association and sometimes can be the first manifestation of endocrine diseases. This condition generally misdiagnosed as weakness and diagnosis and treatment of endocrine diseases are delayed. Especially cushing’s disease, exogen glucocorticoid use, hypothyroidism, hyperaldesteronism and osteomalacia can mimic inflammatory myopathies clinically. Endocrine myopathies are group of disease which must be part of differential diagnosis who has proximal muscle weakness. Statin and glucocorticoid use come to the knowledge of physician because these are the most common cause of drug related proximal myopathy. While evaluating patient with proximal myopathy, thyroid function tests, vitamin D levels, parathyroid hormone must be measured and primary hyperaldesteronism work up when clinically suspicion occurs. Treatment of endocrine myopathies are based on correction of endocrine disorder

Cite

CITATION STYLE

APA

Yeter, H. H. (2015). Endocrine Myopathies: Clinical Review. Endocrinology & Metabolic Syndrome, 04(02). https://doi.org/10.4172/2161-1017.1000178

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free